Urologic-Oncology-Branch
-
An Open-Label Phase 2 Study to Evaluate PT2977 for the Treatment of Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma.
Open - RecruitingNCI Protocol ID NCI-18-C-0138Investigator Ramaprasad Srinivasan, M.D., Ph.D. -
A Phase I Single-Arm Study of the Combination of Durvalumab (MEDI4736) and Vicinium (oportuzumab monatox, VB4-845) in Subjects with High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated with BCG
Open - RecruitingNCI Protocol ID NCI-17-C-0157Investigator Piyush K. Agarwal, M.D. -
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
Open - RecruitingNCI Protocol ID NCI-16-C-0010Investigator Peter A. Pinto, M.D. -
Phase I/II Trial of Vandetanib in Combination with Metformin in Subjects with HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
Open - RecruitingNCI Protocol ID NCI-15-C-0157Investigator Ramaprasad Srinivasan, M.D., Ph.D. -
Care of the Urothelial Cancer Patient and Prospective Collection of Biospecimens from Healthy Volunteers and Urothelial Cancer Patients
Open - RecruitingNCI Protocol ID NCI-15-C-0087Investigator Piyush K. Agarwal, M.D. -
A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
Open - RecruitingNCI Protocol ID NCI-14-C-0037Investigator Ramaprasad Srinivasan, M.D., Ph.D. -
A Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
Open - RecruitingNCI Protocol ID NCI-10-C-0114Investigator Ramaprasad Srinivasan, M.D., Ph.D. -
Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene, and Characterization of the Predisposition to Renal Cancer
Open - RecruitingNCI Protocol ID NCI-03-C-0066Investigator W. Marston Linehan, M.D. -
The Birt Hogg Dubeamp;#39; Syndrome: Identification of the Disease Gene, and Characterization of the Predisposition to Renal Cancer
Open - RecruitingNCI Protocol ID NCI-02-C-0159Investigator W. Marston Linehan, M.D. -
Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Diseases
Open - RecruitingNCI Protocol ID NCI-97-C-0147Investigator W. Marston Linehan, M.D. -
Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
Open - RecruitingNCI Protocol ID NCI-89-C-0086Investigator W. Marston Linehan, M.D.